CDX-3379
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CDX-3379, covering 2020-05-20 to 2023-04-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma [Phase 2]